First-in-human clinical trial to assess gene therapy for Alzheimer’s disease
Asthmatics no higher risk dying from COVID, review of studies on 587,000 people shows
19 February 2021Vaccine passports can work, but face 12 challenges
19 February 2021First-in-human clinical trial to assess gene therapy for Alzheimer’s disease
Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
